The two-month grace period covers all types of visas, including tourist and expired residency permits
Britain will start to roll out Merck’s molnupiravir Covid-19 antiviral pill through a drug trial later this month, Susan Hopkins, Chief Medical Adviser at the UK Health Security Agency said on Sunday.
Last week Britain became the first country in the world to approve the potentially game-changing Covid-19 antiviral pill, jointly developed by U.S.-based Merck & Co Inc and Ridgeback Biotherapeutics.
The government said in October it had secured 480,000 courses of the Merck drug, as well as 250,000 courses of an antiviral pill developed by Pfizer Inc.
Asked about the molnupiravir approval, Hopkins told BBC television: “That is great news and it will start to be rolled out through a drug trial in the end of this month/the beginning of December.”
Hopkins said all the trials so far had been done with the unvaccinated, so this would help understand how it will work in the wider vaccinated population.
“The new Pfizer drug is probably not going to be licensed until the new year some time,” she added. “It is still likely to be a couple of months away.”
The two-month grace period covers all types of visas, including tourist and expired residency permits
Sheikh Mohamed extended his sympathies during a visit to the mourning majlis in Al Ain
According to an official, several people are still feared trapped in the debris
Amateurs Afzaal Ahmad, Parvez Ahmed, and Arbaaz Ahmad shine with an Impressive 89-point performance at the Emirates Golf Club
The Meteorological Organisation that it is closely monitoring what is being circulated on social media
There have been a series of school fires in the country in recent years, many of them which have turned out to be arson
Salama Alfalacy is into realistic art featuring landscapes and wildlife, while Meera Jamal Al Midfa is setting new grounds in performance art and filmmaking
Dubai Police have asked drivers to be extra cautious